Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trialResearch in context

Summary: Background: The atherogenicity of remnant cholesterol (RC), a contributor to residual risk of cardiovascular events, has been underlined by recent guidelines. We aimed to evaluate the relationship between RC levels and the efficacy and safety of genotype-guided dual antiplatelet therapy in...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Anxin Wang, Xue Tian, Xuewei Xie, Hao Li, Jing Jing, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Yongjun Wang, Xia Meng
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2024-01-01
Цуврал:	EClinicalMedicine
Нөхцлүүд:	Remnant cholesterol Ticagrelor-aspirin Clopidogrel-aspirin Recurrent stroke CHANCE-2 trial
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2589537023005345
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!